1,514
Views
5
CrossRef citations to date
0
Altmetric
Pharmaceutical

A long war begins: biosimilars versus patented biologics

&
Pages 1071-1073 | Accepted 21 Jul 2015, Published online: 27 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

George Dranitsaris, Ira Jacobs, Carol Kirchhoff, Robert Popovian & Lesley G Shane. (2017) Drug tendering: drug supply and shortage implications for the uptake of biosimilars. ClinicoEconomics and Outcomes Research 9, pages 573-584.
Read now
François Bocquet & Pascal Paubel. (2016) First monoclonal antibody biosimilars: tackling the challenge of substitution. Journal of Medical Economics 19:6, pages 645-647.
Read now

Articles from other publishers (3)

Antoine Perpoil, Gael Grimandi, Stéphane Birklé, Jean-François Simonet, Anne Chiffoleau & François Bocquet. (2020) Public Health Impact of Using Biosimilars, Is Automated Follow up Relevant?. International Journal of Environmental Research and Public Health 18:1, pages 186.
Crossref
Khurram Rehman, Nadeem Irfan Bukhari & Zaheer-Ud-Din Babar. 2018. Equitable Access to High-Cost Pharmaceuticals. Equitable Access to High-Cost Pharmaceuticals 129 142 .
Hina Mehta, Lille Tidwell & Lance A. Liotta. 2017. Molecular Profiling. Molecular Profiling 379 397 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.